chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had flu shot at noon on 21st of October.  By noon next day had body aches.  Pulse was 100 and body temperature was 99.8.  The fever subsided by midnight.  I still feel fatigued although it has been one week since I had the shot. Vaccine lot No. U1256AA, Manufacturer Adventis
With in an hr. my left thigh muscle hurt and my left knee was starting to stiffen up. In 2 hrs., varicose vein in left thigh was extremely throbbing, I could barely walk on stiff knee.  I had a trouble night of pain on Sunday 2-28, Monday , I could barely walk on left leg  & still had thigh pain, I almost fell down stairs 2x from leg buckling, I did fall down in the kitchen  and the fam. room from knee buckling, not supporting my body. I used heat, ice, rest, ibupfen, advil, tynelol, ben-gay, icyhot, CBD cream. I used it all. Today is one week and the thigh pain is gone but knee is still stiff. It no longer buckles, but I still can not fully walk. I am using a cane. I have been working from home all week, but can not cook for myself. I have to sit in a chair in the shower. I did contact my Dr., who said keep doing everything I am doing, that as long as it getting better every day. I am afraid to take 2nd dose.
Information has been received through the pregnancy registry from a physician concerning a 21 year old female with no pertinent medical history and no drug reactions/allergies who on 15-Feb-2005 and 15-Mar-2005 was vaccinated with the first and second 0.5ml doses of varicella virus vaccine live (Lot # 648317/0439P). There was no concomitant medication. It was noted that the patient discovered she was pregnant on 23-Mar-2005. No symptoms were noted. No other information was available. Unspecified medical attention was sought. There was no product quality complaint. Follow up information indicated that on 02-Feb-2005, the patient was tested for varicella antibodies and the results were negative. The vaccine was not administered for immigration purposes. The patient's LMP was 21-Feb-2005. The expected day of delivery was noted to be November 2005. On 28-Mar-2005. a HCG was positive. The patient had one previous pregnancy that was a still birth or miscarriage at 4-6 weeks. There was no local reaction at the injection site, and there was no varicella or herpes zoster symptoms post vaccination. Additional follow up information indicated on 03-Sep-2005, the patient gave birth to a 2.5 pound male at 27 weeks gestation. The infant was normal. Additional information has been requested. (OMIC)
COVID-19; Breathing had gotten worse; O2 levels were low; Cough; Fever; Difficulty breathing/ shortness of breath; A spontaneous report was received from a consumer concerning her husband, a male patient who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced events cough, fever, difficulty breathing, shortness of breath/dyspnoea, COVID-19, O2 levels were low/ oxygen saturation decreased and breathing had gotten worse/condition aggravated.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (Batch: 001A21A) via unknown route for prophylaxis of COVID-19 infection.  After receiving the vaccine the patient experienced a cough, fever, shortness of breath, and difficulty breathing. He went to a clinic where he was not given a COVID test but was prescribed 5 days of pills and sent home. He then returned the next day because his breathing had gotten worse and was admitted to the hospital for COVID-19. Following admittance he was given oxygen because his O2 levels were very low. He was also given some other medications. The event shortness of breath was considered as medically significant. The events breathing had gotten worse and COVID-19 led to hospitalization. Treatment details included oxygen therapy and some medications.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of events cough, fever, difficulty breathing, shortness of breath, COVID-19, low o2 levels and breathing had gotten worse was not provided.; Reporter's Comments: This case concerns a male of unknown age hospitalized with a serious unexpected event of COVID-19 along with dyspnea, oxygen saturation decreased, condition aggravated and NS unexpected cough and expected pyrexia.  Event onset with unknown latency after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient had their A1C checked in April of 2021 and it was 5.4. Patient received the COVID vaccine (both doses) and just before her 40th birthday she went into the hospital and her A1C was 11. Patient had not had any changes in the few months prior other than some weight loss from working out, not weight gain. Patient required insulin after leaving the hospital. Patient went to the Dr regularly and had labs checked and had not history prior.
Patient received 2nd dose of Moderna vaccine on 1.22.21. She is on warfarin and managed by pharmacy. On 3/10, her INR registered above 8 on the point of care machine. Patient sent to lab for confirmation (will get results next day). Patient is normally stable and reports no other changes that could affect her INR per clinical pharmacist. Only thing identified is the COVID vaccine at the end of January.
A little bump; big red mark, area is red to the touch; Itchy at the site of injection; A spontaneous report was received from a health professional  concerning a 22-year-old, female patient who received Moderna's COVID-19 vaccine and developed itching, a big red mark and a little bump at the injection site.  The patient's medical history was not reported. Concomitant product use was not provided by the reporter.  On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 037k20A) via unknown route in the right arm for prophylaxis of COVID-19 infection.    On 01 Jan 2021, a few days after receiving the vaccine, the patient started to itchy at the injection site. On 05 Jan 2021, the patient developed a big red mark, the area was red to touch and a little bump at the injection site. Treatment information was not provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome for the events, itching, a red mark and a bump at the injection site, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient claims her blood pressure has elevated since the flu shot and she first reported this to me 7 days after the shot.
Patient is complaining of feeling hot, clammy, nauseas, lethargic, and shaky 30 minutes after vaccination. States that she is still feeling lethargic and shaky one hour later. All other symptoms have resolved.
Patient had cataract surgery in mid May, developed shortness of breath after, was seen in ER and admitted.  Found to have stage 4 small cell lung cancer (not a smoker to my knowledge).  Stayed in hospital until June 3rd when he was transferred home to medical center for end of life care.  Died June 7th.
one of the impacted individuals who declined to be re-boosted reported fever following the dose from the expired lot; Moderna Covid-19 vaccine vial with a beyond use date of 03 May 2022 that had been inadvertently used to withdraw six booster doses and administered to six college students on 5 May 2022/ Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (one of the impacted individuals who declined to be re-boosted reported fever following the dose from the expired lot) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine vial with a beyond use date of 03 May 2022 that had been inadvertently used to withdraw six booster doses and administered to six college students on 5 May 2022/ Expired vaccine used) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine vial with a beyond use date of 03 May 2022 that had been inadvertently used to withdraw six booster doses and administered to six college students on 5 May 2022/ Expired vaccine used). On an unknown date, the patient experienced PYREXIA (one of the impacted individuals who declined to be re-boosted reported fever following the dose from the expired lot). At the time of the report, PYREXIA (one of the impacted individuals who declined to be re-boosted reported fever following the dose from the expired lot) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine vial with a beyond use date of 03 May 2022 that had been inadvertently used to withdraw six booster doses and administered to six college students on 5 May 2022/ Expired vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided Treatment medication was not provided by the reporter  It was reported that patient had conveyed to the nurse that given the reaction he was experiencing that he felt an effective dose had been administered.
Patient was feeling faint, had shallow breath, headache, and nausea. Patient was given a snack (at 10:51) and patient started feeling less sick and headache was gone by 10:56. Patient was given water (at 10:58) and started to feel more alert.
has an abscess on her tooth; some reactions with her heart and blood thinner medications; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 73-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Unknown) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunisation. Medical history included heart and blood disorder condition. The patient concomitant medication included heart and blood thinner medications. On an unspecified date, the patient had an abscess on her tooth and wanted to know if there are complications with that and getting the vaccine as patient due to get 2nd dose of vaccine. The patient also mentioned that she was having some reactions with her heart and blood thinner medications. The patient asked if there are any interactions with her heart medications and blood thinners with the vaccine to cause her reactions. It was reported that, the patient was referred to health care profession and informed when vaccinating persons with increased bleeding risk, providers often avoid giving intramuscular injections (not just this vaccine) or choose alternative routes because of the risk for hematoma formation after injections. The Pfizer-BioNTech COVID-19 Vaccine should only be administered as an intramuscular injection. The outcome of event was unknown. Information on the lot/batch number has been requested.
Felt like touch of flu- woke up with headache took ALEVE.  Feels extra tired.  This happens some years when gets flu vaccine also.  Arm is sore.  Injection site warm, red, welt 1 1/2 cm.
after receiving the 1st vaccination shot of maderna, I began to feel sick to my stomach about 1 week after the 1st shot, my stomach will grumble as if I'm starving to death (painful hunger pains) but when I eat, its only 3 or 4 bites of food and then I cannot stomach finishing my meals. I'll then feel as if I'm going to throw it back up, this is every meal this occurs. At times for the past month I've woken up around 1 to 4 am immediately throwing up, even if stomach is empty. Also a very severe case of uric acid buildup and painful GOUT in my entire left ankle joint that's had me bedridden for the last 3 weeks that started a week after my vaccination. I notice I've also been extremely agitated, irritable, restless and not sleeping well.
Chills, fever 103, cough, nausea projectile vomiting - cough began at 6pm - highest fever (103) at 2AM - felt unwell through 10/6/11. Feels "much better" today (10/7/11).
Patient passed out a few seconds after receiving Tdap, MCV4, Hep A and HPV-9. Felt light headed, fainted and face turned white. Lips turned white pt came to, sat up, given crackers and juice.
Patient called 10.19 to report that she had experienced fever, chills and hallucinations the night of the vaccine. Symptoms resolved by the next morning. Patient states she believes this was vaccine related.
Resident has been admitted to the emergency room for tachycardia, awaiting for bed.   confused and incoherent
Nausea, vomiting, dry heaves, excruciating pain radiating from head to toes on right side, huge red circular mark around site of injection, swollen and warm, severe headaches, severe weakness, dizziness, chills and fever.  Lasting five days.
pt recvd vax & devel cellulitis w/knot that lasted for 3 wks;
She started having rapid heartbeat. It increased gradually and lasted about an hour or so, Did not get treatment. But now wears a heart monitor (Zio), for the next two weeks, because of the heart beat issues coming and going. And she did call 911. The fire dept. came first and told her she was ok, and gave her calming techniques.
Approximately 6-8 hours post vax, the pt experienced flu-like symptoms, fever, fatigue, slightly blurred and darkened vision, dehydration, muscle tightness. The pt could not perform duty for 48 hours. The pt stated slept in bed for 14 hours 1st day, 10-12 hours on the second day. The pt also experienced a localized swelling and bump at the site of the injection.
Severe abdominal pain leading to hospitalization.  Surgery revealed significant retroperitoneal bleed, CT angiogram revealed renal artery thrombosis.  Vascular surgery deemed unnecessary at that point and pt placed on Plavix and ASA with output follow-up.  Pt hospitalized from 4/16 - 4/23/2021.  No prior personal or family history of bleeding/clotting disorders, no known precipitating factors other than vaccine.  Pt recovered and was discharged to home with appropriate follow-up.
Having a metallic taste after 2nd Dose/the metallic taste & smell of foods that are starch such as crackers, bread, chips, french fries and batter on chicken; The metallic taste & smell of foods that are starch such as crackers, bread, chips, french fries, and batter on chicken; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 08:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included early onset of macular degeneration. The patient had a cold in Jan2021 and lost some since of taste or smell. But after the cold symptoms disappeared taste and smell came back. Never had fever, cough or breathing problems. The patient was not ever diagnosed as having COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6199) via an unspecified route of administration in the left arm on 14Mar2021 at 09:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 09:00, the patient had a metallic taste after second dose. The metallic taste and smell of foods that are starch such as crackers, bread, chips, french fries, and batter on chicken. If she had dipped the fries and chicken in ketchup or dressings, she could cover the bad taste. The patient had no problems with fruit or vegetables. Still had as of 07Jul2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events had a metallic taste after second dose/ the metallic taste and smell of foods that are starch such as crackers, bread, chips, french fries and batter on chicken was not resolved at the time of this report.
On 8/26/2021 I had noticed that my taste didn't seem to right but I did not think anything of it. Next morning comes around I noticed thats the right side of my face was numb and my eye did not look right, almost looked swollen. So  my wife and I assumed that i was having a allergic reaction to something. I started taking benadryl that day. Next day comes I still seen no difference and then decided to try Claritan D . Well when i woke up the following morning 8/29/21 thats when I realized that something was wrong. My entire right side of my face had fallen, I lost all feeling ang my right eye would not close .   So on 8/29 at around 3-4 am we rushed to the ER, They right away rushed me to the back thinking I had a Stroke. When doctor came in he ask some questions and ask me to move my eye brows in which i could only move the left side. At that point he diagnosed me with Bells Palsy. No test were run and I was released. I was put on a Anti Viral Med and Steroids.   I have been following up with my primary Doctor and she is linking it to the Covid Vaaccine. I to this day still have Bells Palsy! It has not gotten any better at all
Case number PHEH2015US026872 is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 39-year-old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501 and expiry date: May 2016) into left deltoid on 23 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
This spontaneous report was received from a grandmother referring to her grandson, a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concomitant medications were not provided. On an unknown date, the patient was vaccinated with either hepatitis b vaccine (recombinant) (manufacturer unknown) or hepatitis a vaccine, inactivated (manufacturer unknown) for prophylaxis (dose, route of administration, lot# and expiry date were not reported). On an unknown date, the patient developed "hives from the face down to the feet" (urticaria). The grandmother reported that the patient received the vaccine as an infant but at the time of the report, the patient was 25 year old. The outcome of urticaria was unknown. The causality assessment between the aforementioned suspect therapies and the event of urticaria was not reported.
Information has been received from a physician concerning a 14 month old male with no relevant medical history or allergies who on 19-JUN-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (lot number, injection site and route not reported), a dose of MMR II, a dose of PREVNAR and a dose of hepatitis A virus vaccine (unspecified). On 15-JUL-2008 the patient first developed a few spots and was seen in the office on 22-JUL-2008 with worsening head to toe chickenpox. He was prescribed ZOVIRAX and BENADRYL. At the time of reporting, the patient was recovering from the event. According to the physician, full blown chickenpox was considered to be an other important medical event. Additional information has been requested.
Patient complained of nausea and dizziness after vaccine. Patient was sat down and BP was taken. Pt allowed to sit for 20 min in the flu shot room until recovered. Reaction was non-allergenic and attributed to anxiety.
Severe weakness of the upper extremities distally.  Loss of strength in hands, fingers, and wrists, symmetric.  Mild bilateral hand swelling.   Bilateral hand stiffness.  Mild weakness in shoulders.  Morbiliform rash on bilateral upper extremities.
Flushed cheeks and tingling sensation in lower left check and lip. This lasted about 4 hours.
cellulitis noted at injection site, 12 cm & 5 cm per provider. Placed on keflex, 5 ml TID for 10 days
Diagnosed with COVID on 8/17, arrived with hypoxia. Found to have COVID pna and superimposed bacterial pna. Fully vaccinated wiht Moderna. Treated with O2, zinc, vit-c, vit-d, singulair, steroids, lovenox, zithromax. Required intubation 8/26. Eventually went into shock requiring levo, epi and neo and with refractory hypoxia despite full vent support. Care withdrawn and pt expired shortly after.
At right proximal anterolateral thigh, pt has a 1 1/2 cm (diameter) pale area of skin with loss of sub-cutaneous tissue (1st mentioned to physician 8/21/03). Pt was referred for a dermatology consult, refuses appointment.
Redness in face; Flush hot face and neck; Rapid heartbeat; minor allergic reaction to the vaccine; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6203, Expiration date: Unknown), via an unspecified route of administration on an unspecified date in Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Additional context stated that the patient received first dose of the Pfizer vaccine couple weeks ago within the Mar2021 and was scheduled to have the second dose next week reported as a week from today or tomorrow. When the patient was there, the patient had a minor allergic reaction to the vaccine about 3 to 5 minutes shortly after the shot in the arm. The patient had redness in face, flush hot face and neck and felt rapid heartbeat and it lasted for 3-10 minutes. The patient was monitored by a women, they didn't give any Epipen or any thing like that and was recommended that the patient should get some allergy testing before second dose. The patient had not done that and didn't really think all of that was necessary. The patient underwent lab tests and procedures which included heart rate: rapid on an unspecified date in Mar2021. The outcome of the events recovered on an unspecified date in Mar2021.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Right thigh reddened area size of a dime at injection site.  Instructed to use cool compresses and observe.  If any changes in area, call office to be seen by physician.  Information supplied by mother.  When nurse called regarding about another sibling.